International Biotechnology Trust as of Sept. 30, 2019
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 58 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 9.3 | $20M | 316k | 63.38 | |
| Celgene Corporation | 7.8 | $17M | 171k | 99.29 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 6.6 | $14M | 84k | 169.38 | |
| Neurocrine Biosciences (NBIX) | 6.1 | $13M | 147k | 90.06 | |
| Amgen (AMGN) | 5.9 | $13M | 66k | 193.52 | |
| Regeneron Pharmaceuticals (REGN) | 5.1 | $11M | 40k | 277.43 | |
| Alexion Pharmaceuticals | 4.6 | $10M | 102k | 97.92 | |
| D Stemline Therapeutics | 4.0 | $8.7M | 835k | 10.41 | |
| Ptc Therapeutics I (PTCT) | 3.7 | $8.0M | 236k | 33.82 | |
| Illumina (ILMN) | 3.5 | $7.6M | 25k | 304.22 | |
| Biogen Idec (BIIB) | 3.4 | $7.4M | 32k | 232.84 | |
| Incyte Corporation (INCY) | 3.3 | $7.2M | 97k | 74.21 | |
| Insmed (INSM) | 2.9 | $6.3M | 357k | 17.63 | |
| Horizon Therapeutics Pub SHS | 2.7 | $5.9M | 218k | 27.24 | |
| BioMarin Pharmaceutical (BMRN) | 2.7 | $5.9M | 87k | 67.40 | |
| Seattle Genetics | 2.6 | $5.7M | 66k | 85.35 | |
| Amarin Corp Spons Adr New | 1.8 | $3.9M | 259k | 15.16 | |
| Sangamo Biosciences (SGMO) | 1.5 | $3.2M | 350k | 9.05 | |
| Ionis Pharmaceuticals (IONS) | 1.3 | $2.8M | 46k | 59.92 | |
| Alnylam Pharmaceuticals (ALNY) | 1.3 | $2.7M | 34k | 80.33 | |
| ACADIA Pharmaceuticals (ACAD) | 1.1 | $2.4M | 68k | 35.97 | |
| GW Pharmaceuticals Ads | 1.1 | $2.3M | 20k | 114.95 | |
| Sage Therapeutics (SAGE) | 1.0 | $2.2M | 16k | 140.31 | |
| Abiomed | 1.0 | $2.1M | 12k | 177.86 | |
| Kalvista Pharmaceuticals (KALV) | 1.0 | $2.1M | 177k | 11.60 | |
| Sarepta Therapeutics (SRPT) | 0.9 | $2.0M | 26k | 75.33 | |
| Repligen Corporation (RGEN) | 0.9 | $1.8M | 24k | 76.71 | |
| Exelixis (EXEL) | 0.8 | $1.8M | 104k | 17.68 | |
| Myokardia | 0.7 | $1.6M | 30k | 52.13 | |
| Bluebird Bio | 0.7 | $1.6M | 17k | 91.82 | |
| Ascendis Pharma AS Sponsored ADR (ASND) | 0.6 | $1.3M | 14k | 96.30 | |
| Millendo Therapeutics | 0.6 | $1.3M | 178k | 7.11 | |
| Sutro Biopharma (STRO) | 0.6 | $1.3M | 139k | 9.07 | |
| Blueprint Medicines (BPMC) | 0.6 | $1.2M | 17k | 73.53 | |
| Globus Med Inc cl a (GMED) | 0.6 | $1.2M | 24k | 51.12 | |
| Acceleron Pharma | 0.5 | $1.2M | 30k | 39.47 | |
| Agios Pharmaceuticals (AGIO) | 0.5 | $1.2M | 37k | 32.33 | |
| Tricida | 0.5 | $1.1M | 37k | 30.84 | |
| Nektar Therapeutics | 0.5 | $1.1M | 60k | 18.22 | |
| Uniqure Nv SHS (QURE) | 0.5 | $1.1M | 28k | 39.35 | |
| Momenta Pharmaceuticals | 0.5 | $1.0M | 80k | 12.95 | |
| EXACT Sciences Corporation (EXAS) | 0.4 | $967k | 11k | 90.37 | |
| Global Blood Therapeutics In | 0.4 | $897k | 19k | 48.49 | |
| Mirati Therapeutics | 0.4 | $849k | 11k | 77.89 | |
| Halozyme Therapeutics (HALO) | 0.4 | $816k | 53k | 15.50 | |
| Arena Pharmaceuticals | 0.3 | $755k | 17k | 45.76 | |
| Fibrogen | 0.3 | $728k | 20k | 36.95 | |
| Myriad Genetics (MYGN) | 0.3 | $716k | 25k | 28.64 | |
| Deciphera Pharmaceuticals | 0.3 | $577k | 17k | 33.94 | |
| Zogenix | 0.3 | $577k | 14k | 40.07 | |
| Supernus Pharmaceuticals (SUPN) | 0.3 | $548k | 20k | 27.46 | |
| Akcea Therapeutics Inc equities | 0.2 | $488k | 32k | 15.38 | |
| Amicus Therapeutics (FOLD) | 0.2 | $470k | 59k | 8.02 | |
| Radius Health | 0.2 | $437k | 17k | 25.71 | |
| Anaptysbio Inc Common (ANAB) | 0.2 | $350k | 10k | 35.00 | |
| ArQule | 0.1 | $294k | 41k | 7.17 | |
| G1 Therapeutics | 0.1 | $255k | 11k | 22.77 | |
| Dermira | 0.1 | $191k | 30k | 6.37 |
